Acasti Pharma

$0.2643
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0405 (+17.80%) Today
-$0.0037 (-1.38%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell Acasti Pharma and other stocks, options, and ETFs commission-free!

About ACST

Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada. The listed name for ACST is Acasti Pharma, Inc. Class A Common Stock.

CEO
Janelle D'Alvise
Employees
Headquarters
Laval, Québec
Founded
2002
Market Cap
25.97M
Price-Earnings Ratio
Dividend Yield
Average Volume
9.43M
High Today
$0.3273
Low Today
$0.214
Open Price
$0.2219
Volume
34.07M
52 Week High
$3.08
52 Week Low
$0.171

Collections

ACST Earnings

-$0.26
-$0.05
$0.16
$0.37
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
per share
Actual
Available Nov 16, Pre-Market

You May Also Like